XML 89 R76.htm IDEA: XBRL DOCUMENT v3.22.0.1
SHARE-BASED COMPENSATION- Stock Warrants (Details) - USD ($)
12 Months Ended
Dec. 26, 2021
Dec. 27, 2020
Dec. 29, 2019
Dec. 30, 2018
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]        
Exercised (in shares0 600   39,014  
Warrant        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Compensation cost related to stock awards $ 0 $ 0 $ 0  
Unamortized stock compensation expense $ 0      
Unamortized stock compensation expense, recognition period 0 years      
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding [Roll Forward]        
Warrants / Restricted Stock outstanding at beginning of period (in shares) 25,862 64,482 93,216  
Exercised   (38,620) (28,734)  
Warrants / Restricted Stock outstanding at ending of period (in shares) 0 25,862 64,482 93,216
Warrants exercisable (in shares) 0 25,862    
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Weighted Average Exercise Price [Abstract] [Abstract]        
Warrants outstanding at beginning of period (in dollars per share) $ 16.80 $ 13.84 $ 11.59  
Exercised   11.85 6.55  
Warrants outstanding at ending of period (in dollars per share) 0 16.80 $ 13.84 $ 11.59
Warrants exercisable (in dollars per share) $ 0 $ 16.80    
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Additional Disclosures [Abstract]        
Warrants outstanding, weighted remaining contractual life 0 years 4 months 24 days 9 months 18 days 1 year 3 months 18 days
Warrants exercisable, weighted remaining contractual life 0 years 4 months 24 days    
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Intrinsic Value [Abstract]        
Warrants outstanding at beginning of period $ 0 $ 473,000 $ 805,000  
Warrants outstanding at ending of period 0 0 $ 473,000 $ 805,000
Warrants exercisable, total intrinsic value $ 0 $ 0    
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]        
Nonvested, number of warrants / restricted stock 0 0    
Nonvested warrants / restricted stock, weighted average grant date fair value $ 0 $ 0    
Conversion of stock, shares issued (in shares)     20,059  
Exercised (in shares0     28,734  
Forfeited / Canceled (in shares) (25,862)      
Forfeited / Canceled (in dollars per share) $ 16.80